Suppr超能文献

大鼠胃中降钙素基因相关肽引起的一氧化氮依赖性和非依赖性充血

Nitric oxide-dependent and -independent hyperaemia due to calcitonin gene-related peptide in the rat stomach.

作者信息

Holzer P, Lippe I T, Jocic M, Wachter C, Erb R, Heinemann A

机构信息

University of Graz, Department of Experimental and Clinical Pharmacology, Austria.

出版信息

Br J Pharmacol. 1993 Sep;110(1):404-10. doi: 10.1111/j.1476-5381.1993.tb13824.x.

Abstract
  1. Calcitonin gene-related peptide (CGRP) potently enhances mucosal blood flow in the rat stomach. The aim of this study was to examine whether CGRP also dilates extramural arteries supplying the stomach and whether the vasodilator action of CGRP involves nitric oxide (NO). 2. Rat CGRP-alpha (0.03-1 nmol kg-1, i.v.) produced a dose-dependent increase in blood flow through the left gastric artery (LGA) as determined by an ultrasonic transit time technique in urethane-anaesthetized rats. Blockade of NO synthesis by NG-nitro-L-arginine methyl ester (L-NAME, 20 and 60 mumol kg-1, i.v.) significantly reduced basal blood flow (BF) in the LGA and attenuated the hyperaemic activity of CGRP by a factor of 2.8-4. D-NAME tended to enhance basal BF in the LGA but had no influence on the dilator activity of CGRP. The ability of vasoactive intestinal polypeptide to increase left gastric arterial blood flow remained unaltered by L-NAME. 3. L-NAME (20 and 60 mumol kg-1, i.v.) evoked a prompt and sustained rise of mean arterial blood pressure (MAP) and caused a slight decrease in the hypotensive activity of CGRP. In contrast, D-NAME induced a delayed and moderate increase in MAP and did not influence the hypotensive activity of CGRP. 4. Rat CGRP-alpha dilated the isolated perfused bed of the rat LGA precontracted with methoxamine and was 3 times more potent in this respect than rat CGRP-beta. The dilator action of rat CGRP-alpha in this preparation was not affected by L-NAME or D-NAME (40 microM). 5. L-NAME (60 micromol kg-1, i.v.) reduced gastric mucosal blood flow as assessed by laser Doppler flowmetry and diminished the hyperaemic activity of rat CGRP-alpha in the gastric mucosa by a factor of 4.5, whereas D-NAME was without effect.6. These data show that CGRP is a potent dilator of mucosal and extramural resistance vessels in the rat stomach. Its dilator action involves both NO-dependent and NO-independent mechanisms.
摘要
  1. 降钙素基因相关肽(CGRP)可有效增强大鼠胃黏膜血流量。本研究旨在探讨CGRP是否也能扩张供应胃的壁外动脉,以及CGRP的血管舒张作用是否涉及一氧化氮(NO)。2. 在氨基甲酸乙酯麻醉的大鼠中,采用超声渡越时间技术测定,大鼠CGRP-α(0.03 - 1 nmol·kg⁻¹,静脉注射)使通过胃左动脉(LGA)的血流量呈剂量依赖性增加。NG-硝基-L-精氨酸甲酯(L-NAME,20和60 μmol·kg⁻¹,静脉注射)阻断NO合成,显著降低LGA的基础血流量(BF),并使CGRP的充血活性减弱2.8 - 4倍。D-NAME倾向于增强LGA的基础BF,但对CGRP的舒张活性无影响。血管活性肠肽增加胃左动脉血流量的能力不受L-NAME影响。3. L-NAME(20和60 μmol·kg⁻¹,静脉注射)使平均动脉血压(MAP)迅速持续升高,并使CGRP的降压活性略有降低。相比之下,D-NAME使MAP延迟适度升高,且不影响CGRP的降压活性。4. 大鼠CGRP-α使预先用甲氧明收缩的大鼠LGA离体灌注床舒张,在这方面其效力是大鼠CGRP-β的3倍。大鼠CGRP-α在该制剂中的舒张作用不受L-NAME或D-NAME(40 μM)影响。5. 激光多普勒血流仪评估显示,L-NAME(60 μmol·kg⁻¹,静脉注射)降低胃黏膜血流量,并使大鼠CGRP-α在胃黏膜中的充血活性减弱4.5倍,而D-NAME无作用。6. 这些数据表明,CGRP是大鼠胃黏膜和壁外阻力血管的强效舒张剂。其舒张作用涉及NO依赖和NO非依赖机制。

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验